Literature DB >> 33519449

A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection.

Juwairiah Remali1, Wan Mohd Aizat1.   

Abstract

The rapid outbreak of coronavirus disease 2019 (COVID-19) has demonstrated the need for development of new vaccine candidates and therapeutic drugs to fight against the underlying virus, severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Currently, no antiviral treatment is available to treat COVID-19 as treatment is mostly directed to only relieving the symptoms. Retrospectively, herbal medicinal plants have been used for thousands of years as a medicinal alternative including for the treatment of various viral illnesses. However, a comprehensive description using various medicinal plants in treating coronavirus infection has not to date been described adequately, especially their modes of action. Most other reports and reviews have also only focused on selected ethnobotanical herbs such as Traditional Chinese Medicine, yet more plants can be considered to enrich the source of the anti-viral compounds. In this review, we have screened and identified potential herbal medicinal plants as anti-coronavirus medication across major literature databases without being limited to any regions or ethnobotanic criteria. As such we have successfully gathered experimentally validated in vivo, in vitro, or in silico findings of more than 30 plants in which these plant extracts or their related compounds, such as those of Artemisia annua L., Houttuynia cordata Thunb., and Sambucus formosana Nakai, are described through their respective modes of action against specific mechanisms or pathways during the viral infection. This includes inhibition of viral attachment and penetration, inhibition of viral RNA and protein synthesis, inhibition of viral key proteins such as 3-chymotrypsin-like cysteine protease (3CLpro) and papain-like protease 2 (PLpro), as well as other mechanisms including inhibition of the viral release and enhanced host immunity. We hope this compilation will help researchers and clinicians to identify the source of appropriate anti-viral drugs from plants in combating COVID-19 and, ultimately, save millions of affected human lives.
Copyright © 2021 Remali and Aizat.

Entities:  

Keywords:  COVID-19; SARS; Traditional Chinese medicine (TCM); drug; herb; medicinal plant; natural products; viral infection

Year:  2021        PMID: 33519449      PMCID: PMC7845143          DOI: 10.3389/fphar.2020.589044

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  13 in total

Review 1.  Genus Sophora: a comprehensive review on secondary chemical metabolites and their biological aspects from past achievements to future perspectives.

Authors:  Howaida I Abd-Alla; Dalila Souguir; Mohamed O Radwan
Journal:  Arch Pharm Res       Date:  2021-12-15       Impact factor: 4.946

Review 2.  Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?

Authors:  Pawan K Agrawal; Chandan Agrawal; Gerald Blunden
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

3.  Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering.

Authors:  Fan Yang; Qi Zhang; Zhongshang Yuan; Saisai Teng; Lizhen Cui; Fuzhong Xue; Leyi Wei
Journal:  Front Pharmacol       Date:  2021-12-24       Impact factor: 5.810

4.  Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic.

Authors:  Jia-Bo Wang; Adolfo Andrade-Cetto; Javier Echeverria; Jon Wardle; Hung-Rong Yen; Michael Heinrich
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

5.  Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63.

Authors:  Monika Horvat; Martina Avbelj; María Beatriz Durán-Alonso; Mihailo Banjanac; Hrvoje Petković; Jernej Iskra
Journal:  Molecules       Date:  2021-11-11       Impact factor: 4.411

Review 6.  Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.

Authors:  Priyanka Saha; Subhankar Bose; Amit Kumar Srivastava; Anis Ahmad Chaudhary; Rajiv Lall; Sahdeo Prasad
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

Review 7.  Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Mohammed A Garout; Ayman M Al-Qaaneh; Anupam A Sule; Raghavendra Tirupathi; Abbas Al Mutair; Saad Alhumaid; Abdulkarim Hasan; Manish Dhawan; Ruchi Tiwari; Khan Sharun; Ranjan K Mohapatra; Saikat Mitra; Talha Bin Emran; Muhammad Bilal; Rajendra Singh; Salem A Alyami; Mohammad Ali Moni; Kuldeep Dhama
Journal:  Pathogens       Date:  2021-05-07

Review 8.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

9.  Network Analysis of Herbs Recommended for the Treatment of COVID-19.

Authors:  Lin Ang; Hye Won Lee; Anna Kim; Jun-Yong Choi; Myeong Soo Lee
Journal:  Infect Drug Resist       Date:  2021-05-18       Impact factor: 4.003

10.  Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study.

Authors:  Nashwah G M Attallah; Aya H El-Kadem; Walaa A Negm; Engy Elekhnawy; Thanaa A El-Masry; Elshaymaa I Elmongy; Najla Altwaijry; Ashwag S Alanazi; Gadah Abdulaziz Al-Hamoud; Amany E Ragab
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.